Oppenheimer & Co. Inc. Decreases Stock Position in Celsius Holdings, Inc. (NASDAQ:CELH)

Oppenheimer & Co. Inc. lowered its stake in Celsius Holdings, Inc. (NASDAQ:CELH) by 72.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 11,911 shares of the company’s stock after selling 31,563 shares during the period. Oppenheimer & Co. Inc.’s holdings in Celsius were worth $374,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CELH. Massachusetts Financial Services Co. MA boosted its position in shares of Celsius by 231.2% during the second quarter. Massachusetts Financial Services Co. MA now owns 3,946,208 shares of the company’s stock valued at $225,289,000 after buying an additional 2,754,722 shares during the last quarter. Bank of New York Mellon Corp lifted its position in Celsius by 36.7% during the second quarter. Bank of New York Mellon Corp now owns 2,942,433 shares of the company’s stock valued at $167,983,000 after purchasing an additional 790,014 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its position in Celsius by 0.3% in the first quarter. Price T Rowe Associates Inc. MD now owns 2,802,264 shares of the company’s stock worth $232,365,000 after buying an additional 9,054 shares during the last quarter. Capital Research Global Investors purchased a new stake in shares of Celsius in the first quarter worth approximately $99,746,000. Finally, Dimensional Fund Advisors LP increased its position in shares of Celsius by 86.9% during the second quarter. Dimensional Fund Advisors LP now owns 990,135 shares of the company’s stock worth $56,531,000 after acquiring an additional 460,227 shares during the period. 60.95% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

CELH has been the subject of several recent analyst reports. Truist Financial boosted their price objective on shares of Celsius from $30.00 to $35.00 and gave the stock a “hold” rating in a research note on Wednesday, October 16th. Morgan Stanley reiterated an “equal weight” rating and set a $50.00 price objective on shares of Celsius in a report on Tuesday, August 20th. Jefferies Financial Group lowered their price objective on Celsius from $53.00 to $48.00 and set a “buy” rating for the company in a research report on Thursday, October 10th. B. Riley decreased their price target on Celsius from $50.00 to $47.00 and set a “buy” rating for the company in a research note on Monday, November 4th. Finally, Piper Sandler dropped their price target on Celsius from $50.00 to $47.00 and set an “overweight” rating on the stock in a research note on Tuesday, September 24th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $54.40.

Insider Buying and Selling

In related news, CEO John Fieldly sold 74,847 shares of the company’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $32.80, for a total value of $2,454,981.60. Following the completion of the transaction, the chief executive officer now directly owns 1,812,490 shares of the company’s stock, valued at approximately $59,449,672. This represents a 3.97 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 2.20% of the stock is owned by insiders.

Celsius Stock Up 4.8 %

Shares of Celsius stock opened at $29.05 on Friday. The company has a 50-day simple moving average of $31.05 and a 200 day simple moving average of $48.48. The stock has a market capitalization of $6.83 billion, a P/E ratio of 40.35, a price-to-earnings-growth ratio of 3.13 and a beta of 1.86. Celsius Holdings, Inc. has a 12-month low of $25.23 and a 12-month high of $99.62.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.